SkyAI (STSS) Revenue & Revenue Breakdown
SkyAI Revenue Highlights
Latest Revenue (Y)
$204.12K
Latest Revenue (Q)
$192.78K
SkyAI Revenue by Period
SkyAI Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $204.12K | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
SkyAI generated $204.12K in revenue during NA 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
SkyAI Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $192.78K | -288.59% |
| 2025-12-31 | $-102.22K | -104.47% |
| 2025-09-30 | $2.29M | 927.76% |
| 2025-06-30 | $222.72K | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
SkyAI generated $192.78K in revenue during Q1 2026, up -288.59% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
SkyAI Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.71B | $1.26B |
| CCLD | CareCloud | $120.50M | $31.27M |
| PDEX | Pro-Dex | $66.59M | $19.95M |
| JYNT | Joint | $54.90M | $14.82M |
| RPID | Rapid Micro Biosystems | $33.59M | $8.00M |
| STSS | SkyAI | $204.12K | $192.78K |
| SERA | Sera Prognostics | $81.00K | $17.00K |
| MBOT | Microbot Medical | - | $105.00K |
| CGTX | Cognition Therapeutics | - | - |
| GLSI | Greenwich LifeSciences | - | - |
| IXHL | Incannex Healthcare | - | - |